EPISODE · Jul 15, 2026 · 7 MIN
10th European Congress on Perspectives in Lung Cancer, Brussels
from Oncology Times - OncTimes Talk
Silvia Novello and Giorgio Scagliotti on harnessing insulin-like growth factor receptor inhibition in a Phase II study that showed clinical activity of figitumumab to be at least as good as that of inhibitors of other growth factors already being used in cancer.
NOW PLAYING
10th European Congress on Perspectives in Lung Cancer, Brussels
0:00
7:43
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Oncology Times - OncTimes Talk?
This episode is 7 minutes long.
When was this Oncology Times - OncTimes Talk episode published?
This episode was published on July 15, 2026.
What is this episode about?
Silvia Novello and Giorgio Scagliotti on harnessing insulin-like growth factor receptor inhibition in a Phase II study that showed clinical activity of figitumumab to be at least as good as that of inhibitors of other growth factors already being...
Can I download this Oncology Times - OncTimes Talk episode?
Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!